Kaneka Corporation (KANKF) Stock

About Kaneka Corporation

Kaneka Corporation, established in Tokyo, Japan, in 1949, functions as a globally diversified manufacturer. The company's extensive chemical and advanced materials portfolio includes a broad spectrum of polyvinyl chloride (PVC) products, such as crosslinked, paste, and chlorinated PVC, alongside PVC-PVAc polymers and acryl grafted-vinyl chloride copolymers. It also provides various chemical additives like impact modifiers, processing aids, specialty additives, and tougheners for thermosetting resins. Its specialized polymer offerings feature silyl-terminated polyether, acrylic silicon, terminally reactive liquid acrylic, biodegradable polymers, high-performance engineering resins for injection molding, materials with zero birefringence, acrylic films, and isobutylene-based thermoplastic elastomers. Beyond polymers, Kaneka manufactures an array of foams, including polypropylene, Kanelite, and extruded polystyrene insulation. Its advanced film products encompass polyimide film, transparent films for optical applications, highly thermally conductive graphite sheets, multi-layer insulation, and transparent conductive films, in addition to thermo-resistant and light-resistant transparent resin products. In the energy and cutting-edge materials sector, Kaneka develops photovoltaic power generation systems for residential, public, and industrial installations. Its innovative product range extends to eco-friendly fur, flame-retardant substances, hair accessories, other novel materials, organic EL lighting panels, and biosurfactants. The corporation also holds a significant presence in healthcare and life sciences. It delivers medical products for intervention, blood purification, and gastroenterology, alongside diagnostic testing equipment, regenerative medicine and cell therapy solutions, and genetic diagnostic products. Its pharmaceutical contributions include low molecular pharmaceutical materials, affinity chromatography resins for monoclonal antibody purification, biopharmaceuticals, transdermal medicines, and even specialized innerwear with shock-absorbing properties. Lastly, Kaneka offers a comprehensive selection of food and nutritional products. This segment covers dairy items, margarines, fats and oils, whipping creams, fillings, baker's yeast and dough improvers, processed fruits, butter, shortening, cacao butter alternatives, various kneading creams, frozen dough, spices, and antifreeze materials. Furthermore, the company supplies specialized pharma and supplemental nutrition solutions, such as coenzyme, lactic-acid bacteria, and other functional foodstuffs, alongside agricultural fertilizers.

Kaneka Corporation is headquartered in JP.

Kaneka Corporation (KANKF) stock trades at $30.28 with a market capitalization of $1.82B. The stock is valued at a price-to-earnings (P/E) ratio of 11.62, price-to-book of 0.72, price-to-sales of 0.43. Over the past 52 weeks the stock has ranged between $24.90 and $30.28, and currently trades at its 52-week high. It pays a dividend yielding 4.26%.

On profitability, Kaneka Corporation generates a return on equity (ROE) of 6.43%, return on capital employed of 4.83%, an operating margin of 3.90%, a net profit margin of 3.82%.

Official website: www.kaneka.co.jp